Sunflower seeds may offer significant digestive, nutritional, and gut bacteria benefits for children with cystic fibrosis (CF), according to…
Lila Levinson, PhD
Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the University of Washington Computational Neuroscience Center. She enjoys exploring the Pacific Northwest and spending time with her cat, Fibonacci.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lila Levinson, PhD
KIT2014, an experimental inhaled therapy by Kither Biotech, was safe and well tolerated in healthy volunteers, according to Phase…
For adults with cystic fibrosis (CF), long-term treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) may significantly improve the composition of bacteria…
The real-world health benefits that cystic fibrosis (CF) patients experienced when they started taking Trikafta (elexacaftor/tezacaftor/ivacaftor) during the…
Six months of treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) helped open the nasal and sinus passages in people with cystic…
The U.S. approval of CFTR modulators for cystic fibrosis (CF) may have reduced or delayed the need for liver transplants…
While treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) helps people with cystic fibrosis (CF) gain weight, a tendency toward unhealthy diets may…
One-year treatment with Trikafta — a widely used, approved medication for people with cystic fibrosis (CF) — significantly…
Northwestern University scientists developed a wearable patch that could help cystic fibrosis (CF) patients manage their disease from home. A…
The Food and Drug Administration (FDA) placed the U.S. portion of a Phase 2b trial of BX004, a treatment for…